terbutaline has been researched along with Dyspnea in 16 studies
Terbutaline: A selective beta-2 adrenergic agonist used as a bronchodilator and tocolytic.
terbutaline : A member of the class of phenylethanolamines that is catechol substituted at position 5 by a 2-(tert-butylamino)-1-hydroxyethyl group.
Dyspnea: Difficult or labored breathing.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the effects of nebulised saline and nebulised terbutaline on breathlessness at rest in patients with severe COPD." | 9.08 | The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD). ( Black, PN; Brodie, SM; Poole, PJ; Stewart, JM, 1998) |
| "The study was designed to compare terbutaline inhaled via a 750 ml spacer (Nebuhaler) with subcutaneous adrenaline injection as a first-line treatment for acute severe asthma." | 9.06 | Terbutaline pressurised aerosol inhaled via a Nebuhaler--an effective alternative to subcutaneous adrenaline for treatment of acute severe asthma. ( Charoenratanakul, S; Youngchaiyud, P, 1987) |
| "In COPD patients, additional administration of transdermal tulobuterol to inhaled tiotropium produced significant benefits in dyspnea and SGRQ score as well as pulmonary function." | 5.14 | Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD. ( Fukuchi, Y; Ichinose, M; Kubo, K; Mishima, M; Nagai, A; Nishimura, M; Seyama, K, 2010) |
| " We examined the effect of adding a long-acting anti-cholinergic agent (tiotropium) to a transdermal-type beta(2)-agonist (tulobuterol) on dyspnea as well as pulmonary function." | 5.12 | Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist. ( Akamatsu, K; Hirano, T; Ichikawa, T; Ichinose, M; Maeda, S; Matsunaga, K; Minakata, Y; Miura, K; Nakanishi, M; Takahashi, T; Ueshima, K; Yamagata, T; Yamagata, Y; Yanagisawa, S, 2007) |
| "To compare the effects of nebulised saline and nebulised terbutaline on breathlessness at rest in patients with severe COPD." | 5.08 | The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD). ( Black, PN; Brodie, SM; Poole, PJ; Stewart, JM, 1998) |
| "In order to study the mechanism underlying early morning dyspnea in patients with chronic airflow obstruction, the relation was assessed between the diurnal variation of FEV1, plasma and urinary catecholamines, and urinary histamine (metabolites) in eight nonallergic patients (mean age, 53 years)." | 5.06 | Influence of slow-release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstruction. ( Keyzer, JJ; Koëter, GH; Meurs, H; Postma, DS, 1986) |
| "The study was designed to compare terbutaline inhaled via a 750 ml spacer (Nebuhaler) with subcutaneous adrenaline injection as a first-line treatment for acute severe asthma." | 5.06 | Terbutaline pressurised aerosol inhaled via a Nebuhaler--an effective alternative to subcutaneous adrenaline for treatment of acute severe asthma. ( Charoenratanakul, S; Youngchaiyud, P, 1987) |
| "Treatment of COPD patients with TP is more effective than with theophylline." | 2.73 | Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline. ( Aizawa, H; Gohara, R; Ichiki, M; Iwanaga, T; Kawayama, T; Kinoshita, M; Koga, H; Minami, S; Nishiyama, M; Sueyasu, Y, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 6 (37.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pelkonen, AS | 1 |
| Malmström, K | 1 |
| Malmberg, LP | 1 |
| Sarna, S | 1 |
| Turpeinen, M | 1 |
| Kajosaari, M | 1 |
| Haahtela, T | 1 |
| Mäkelä, MJ | 1 |
| Ichinose, M | 2 |
| Seyama, K | 1 |
| Nishimura, M | 1 |
| Fukuchi, Y | 1 |
| Nagai, A | 1 |
| Mishima, M | 1 |
| Kubo, K | 1 |
| Orosz, SE | 1 |
| Lichtenberger, M | 1 |
| Akamatsu, K | 1 |
| Yamagata, T | 1 |
| Takahashi, T | 1 |
| Miura, K | 1 |
| Maeda, S | 1 |
| Yamagata, Y | 1 |
| Ichikawa, T | 1 |
| Yanagisawa, S | 1 |
| Ueshima, K | 1 |
| Hirano, T | 1 |
| Nakanishi, M | 1 |
| Matsunaga, K | 1 |
| Minakata, Y | 1 |
| Minami, S | 1 |
| Kawayama, T | 1 |
| Ichiki, M | 1 |
| Nishiyama, M | 1 |
| Sueyasu, Y | 1 |
| Gohara, R | 1 |
| Kinoshita, M | 1 |
| Koga, H | 1 |
| Iwanaga, T | 1 |
| Aizawa, H | 1 |
| Zehner, WJ | 1 |
| Scott, JM | 1 |
| Iannolo, PM | 1 |
| Ungaro, A | 1 |
| Terndrup, TE | 1 |
| Janson, C | 1 |
| Herala, M | 1 |
| Noseda, A | 2 |
| Schmerber, J | 2 |
| Prigogine, T | 2 |
| Yernault, JC | 2 |
| Poole, PJ | 1 |
| Brodie, SM | 1 |
| Stewart, JM | 1 |
| Black, PN | 1 |
| Vialatte, J | 1 |
| Hansen, NC | 1 |
| May, O | 1 |
| Stoller, JK | 1 |
| Wiedemann, HP | 1 |
| Loke, J | 1 |
| Snyder, P | 1 |
| Virgulto, J | 1 |
| Matthay, RA | 1 |
| Postma, DS | 2 |
| Koëter, GH | 2 |
| Keyzer, JJ | 2 |
| Meurs, H | 2 |
| Youngchaiyud, P | 1 |
| Charoenratanakul, S | 1 |
12 trials available for terbutaline and Dyspnea
| Article | Year |
|---|---|
Budesonide improves decreased airway conductance in infants with respiratory symptoms.
Topics: Administration, Oral; Airway Resistance; Bronchodilator Agents; Budesonide; Child, Preschool; Cough; | 2009 |
Additive effects of transdermal tulobuterol to inhaled tiotropium in patients with COPD.
Topics: Administration, Cutaneous; Administration, Inhalation; Aged; Bronchodilator Agents; Dose-Response Re | 2010 |
Improvement of pulmonary function and dyspnea by tiotropium in COPD patients using a transdermal beta(2)-agonist.
Topics: Administration, Cutaneous; Administration, Inhalation; Adrenergic beta-Agonists; Aged; Bronchodilato | 2007 |
Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline.
Topics: Activities of Daily Living; Administration, Cutaneous; Aged; Aged, 80 and over; Bronchodilator Agent | 2008 |
Terbutaline vs albuterol for out-of-hospital respiratory distress: randomized, double-blind trial.
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Bronchodilator Agents; Double-Blind Method; Dysp | 1995 |
Dyspnea in acute asthma: relationship with other clinical and physiologic variables.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Airway Obstruction; Aminophylline; Asthm | 1993 |
The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD).
Topics: Adrenergic beta-Agonists; Aerosols; Aged; Aged, 80 and over; Cross-Over Studies; Dose-Response Relat | 1998 |
Domiciliary nebulized terbutaline in severe chronic airways obstruction.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Double-Blind Method; Dyspnea; Female; Forced Ex | 1990 |
Terbutaline and diaphragm function in chronic obstructive pulmonary disease: a double-blind randomized clinical trial.
Topics: Aged; Clinical Trials as Topic; Diaphragm; Double-Blind Method; Dyspnea; Humans; Lung Diseases, Obst | 1988 |
Influence of slow-release terbutaline on the circadian variation of catecholamines, histamine, and lung function in nonallergic patients with partly reversible airflow obstruction.
Topics: Adult; Circadian Rhythm; Clinical Trials as Topic; Delayed-Action Preparations; Dyspnea; Epinephrine | 1986 |
Terbutaline pressurised aerosol inhaled via a Nebuhaler--an effective alternative to subcutaneous adrenaline for treatment of acute severe asthma.
Topics: Acute Disease; Adolescent; Adult; Aerosols; Asthma; Double-Blind Method; Dyspnea; Epinephrine; Femal | 1987 |
Effect of oral slow-release terbutaline on early morning dyspnoea.
Topics: Administration, Oral; Adult; Clinical Trials as Topic; Delayed-Action Preparations; Dyspnea; Humans; | 1985 |
4 other studies available for terbutaline and Dyspnea
| Article | Year |
|---|---|
Avian respiratory distress: etiology, diagnosis, and treatment.
Topics: Analgesics, Opioid; Animals; Bird Diseases; Birds; Bronchodilator Agents; Butorphanol; Dyspnea; Emer | 2011 |
How do patients with either asthma or COPD perceive acute bronchodilation?
Topics: Asthma; Bronchi; Dyspnea; Female; Humans; Linear Models; Lung Diseases, Obstructive; Male; Middle Ag | 1993 |
[Use of beta-adrenergic drugs in pediatric therapy].
Topics: Adrenergic beta-Agonists; Age Factors; Albuterol; Asthma; Child; Dyspnea; Humans; Isoproterenol; Met | 1976 |
Perceived effect on shortness of breath of an acute inhalation of saline or terbutaline: variability and sensitivity of a visual analogue scale in patients with asthma or COPD.
Topics: Asthma; Dyspnea; Female; Forced Expiratory Volume; Humans; Lung Diseases, Obstructive; Male; Middle | 1992 |